In vitro studies of cerebrospinal fluid indicate that normal cerebrosp
inal fluid contains very low levels of fibrinolytic enzymes but that f
ibrinolytic activity is higher in pathologic compared with normal cond
itions and in older compared with younger patients. Because of the low
endogenous fibrinolytic activity of the central nervous system, intra
ventricular fibrinolytic therapy has been studied in adult and pediatr
ic patients for the treatment of intraventricular hemorrhage/posthemor
rhagic hydrocephalus and subarachnoid hemorrhage with secondary cerebr
al vasospasm, A review of the literature about endogenous and exogenou
s fibrinolysis studies of animals, adult humans, and pediatric humans
reveals a record of predominant safety and efficacy, Although its use
in the adult population for the treatment of subarachnoid hemorrhage w
ith secondary vasospasm has become an accepted therapy in some centers
, its use in the pediatric population is less common, It is no longer
considered in the treatment of meningitis, but its role in the treatme
nt of intraventricular hemorrhage/posthemorrhagic hydrocephalus is sti
ll being investigated. (C) 1998 by Elsevier Science Inc. All rights re
served.